ELUCIDATE FFRct Study | MicrobiomeTrials← Back to trialsNCT06018194
ELUCIDATE FFRct Study
CompletedOBSERVATIONAL
Trial Details
Start: 2023-09-01Est. Completion: 2025-07-28
Enrollment target: 439 participants Locations- Cardiovascular Medical Group of Southern California, Beverly Hills, California, United States
- Piedmont Healthcare, Atlanta, Georgia, United States
- Parkview Health, Fort Wayne, Indiana, United States
- Midwest Heart and Vascular Specialists, Overland Park, Kansas, United States
- Valley Health System, Ridgewood, New Jersey, United States
- Mount Sinai Morningside, New York, New York, United States
- Ascension Medical Group, Nashville, Tennessee, United States
- University of Virginia, Charlottesville, Virginia, United States
Other microbiome trials you might be interested in
Systemic SclerosisScleroderma
The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus place…
Scottsdale, United StatesEst. completion Jan 6, 2027
Chronic Kidney DiseaseCoronary Arteries CalcificationsCXCR2 Expression
Chronic kidney disease (CKD) is associated with the development of coronary arteries calcifications (CAC) and increased …
Amiens, FranceEst. completion Aug 2029
Erectile Dysfunction and Coronary Artery Disease
This study provides a comprehensive bidirectional assessment to determine the prevalence, clinical severity, and anatomi…
Multiple LocationsEst. completion Aug 2028